Marcelo Chiara Bertolami

Author

Instituto Dante Pazzanese de Cardiologia ORCID

Also Known As

André Árpád Faludi, Bertolami, Marcelo Chiara, Bertolami,Marcelo Chiara, D Abdalla, Lopes, Luciano M Baracioli, M Bertolami, M C Bertolami, M. Bertolami, M. C. Bertolami

173

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Instituto Dante Pazzanese de Cardiologia Universidade de São Paulo Hospital Universitário da Universidade de São Paulo Universidade Federal de São Paulo Universidad de La Frontera

About

Marcelo Chiara Bertolami is an author at Instituto Dante Pazzanese de Cardiologia specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	28	1.3K
2	Public Health	11	11	386
3	Health Sciences	5	5	199
4	Biochemistry	5	5	197
5	Natural Sciences	1	1	36

Marcelo Chiara Bertolami

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019 Dalton Bertolim Précoma, Gláucia Maria Moraes de Oliveira, Antônio Felipe Leite Simão, Arquivos Brasileiros de Cardiologia	2019	423
Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients E Ascer, Marcelo Chiara Bertolami, Margareth L. Venturinelli, Atherosclerosis InflammationMetabolic SyndromeHypercholesterolemic PatientsCardiovascular DiseaseMedicine	2004	193
Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment Alfredo Halpern, Márcio C. Mancini, Maria Eliane Campos Magalhães, Diabetology & Metabolic Syndrome	2010	169
The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events F Mindlen, Roberto Nordaby, M I Soto Ruiz, Queensland's institutional digital repository (The University of Queensland) Non-pharmacological InterventionPreventive MedicineCardiovascular DiseaseAntihypertensive TherapyClinical Trials	1996	154
Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II Christie M. Ballantyne, Marcelo Chiara Bertolami, Hugo R Hernández García, American Heart Journal Health PolicyCardiovascular DiseaseB Target LevelsHyperlipidemiaLdl Cholesterol	2006	112
Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus Simone Ferderbar, Edimar Cristiano Pereira, Elaine Apolinário, Diabetes/Metabolism Research and Reviews	2006	80
Biomarkers of oxidative stress and endothelial dysfunction in glucose intolerance and diabetes mellitus Edimar Cristiano Pereira, Simone Ferderbar, Marcelo Chiara Bertolami, Clinical Biochemistry InflammationMetabolic SyndromeBiochemistryLipid PeroxidationDiabetes	2008	71
CYP3A5⁎3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia Maria Alice V. Willrich, Mário Hiroyuki Hirata, Fabiana Dalla Vecchia Genvigir, Clinica Chimica Acta Molecular PharmacologyCardiovascular DiseaseMedicinePhysiologyHyperlipidemia	2008	63
High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent Alice Cristina Rodrigues, Ivanise Marina Moretti Rebecchi, Marcelo Chiara Bertolami, Brazilian Journal of Medical and Biological Research	2005	63
Lipid peroxidation and antioxidants in hyperlipidemia and hypertension Patrícia Moriel, Frida Liane Plavnik, Maria Teresa Zanella, Biological Research Metabolic SyndromeHypertensionCardiovascular DiseaseBiochemistryHuman Diseases	2000	62

Page 1